CAMP4 THERAPEUTICS CORPORATION (CAMP)
Healthcare
Biotechnology
4.20 $
+22.0%
vs. previous close
Closing price · As of: 3. Aug 2026
CAMP4 THERAPEUTICS CORPORATION (CAMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.0 | -6.6 | -12 | -11 | -13 | -9.7 | -11 | -14 | -10 | -11 | 6.3 | -11 | -26 | |
| 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 1.7 | |
| 0.8 | 0.7 | 0.6 | 0.9 | 0.8 | 1.6 | 0.8 | 0.9 | 1.0 | 1.0 | 1.2 | 1.5 | 4.6 | |
| -1.6 | 3.1 | -0.2 | -1.4 | -1.5 | 0.2 | 0.8 | -3.7 | 0.4 | -0.4 | 17 | -0.9 | 16 | |
| 0.1 | 0.2 | 0.2 | 0.0 | 0.2 | 0.0 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -2.0 | -0.2 | -0.2 | 0.0 | -0.2 | -0.2 | -0.3 | -0.3 | -0.3 | 0.0 | – | – | – | |
| – | – | – | – | – | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| -0.3 | -0.2 | -0.1 | -0.2 | -0.8 | -0.4 | 73 | -0.2 | 0.1 | 47 | 29 | 0.1 | 76 | |
| -7.0 | -7.0 | -12 | -11 | -14 | -10 | 62 | -15 | -10 | 36 | 35 | -11 | 50 | |
| -3.1 | -6.8 | -12 | -11 | -14 | -9.7 | -12 | -15 | -10 | -11 | 6.3 | -11 | -26 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.